Elevated frequencies of hypoxanthine phosphoribosyltransferase lymphocyte mutants are detected in Russian liquidators 6 to 10 years after exposure to radiation from the Chernobyl nuclear power plant accident

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 439, Issue 1, 1999, Pages 105-119

  Thomas, Cynthia B ^a   Nelson, David O ^a   Pleshanov, Pavel ^b   Vorobstova, Irina ^b   Tureva, Ludmila ^c   Jensen, Ronald ^d   Jones, Irene M ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^c Tula Diagnostic Center   (Russian Federation)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chernobyl; HPRT; Human population; Mutation; Radiation

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; CHERNOBYL ACCIDENT; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MUTATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION EXPOSURE; RUSSIAN FEDERATION;

ACCIDENTS, RADIATION; ADULT; AGE FACTORS; CLONE CELLS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MUTATION; OCCUPATIONAL EXPOSURE; POWER PLANTS; RADIOMETRY; REGRESSION ANALYSIS; RUSSIA; SMOKING; UKRAINE;

EID: 0033514471     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00179-X     Document Type: Article

References (78)

1. Neel J.V. Update on the genetic effects of ionizing radiation. J.A.M.A. 266:1991;698-701.
2. Olshan A.F. Lessons learned from epidemiologic studies of environmental exposure and genetic disease. Environ. Mol. Mutagen. 26:1995;74-80.
3. Nussbaum R.H., Kohnlein W. Inconsistencies and open questions regarding low-dose health effects of ionizing radiation. Environ. Health Perspect. 102:1994;656-667.
4. Olden K., Klein J.L. Environmental health science research and human risk assessment. Mol. Carcinog. 14:1995;2-9.
5. Chakraborty R., Little M.P., Sankaranarayanan K. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers: III. Effects of incomplete penetrance and dose-dependent radiosensitivity on cancer risks in populations. Rad. Res. 147:1997;309-320.
6. Sankaranarayanan K., Chakraborty R. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancer: I. Background. Rad. Res. 143:1995;121-143.
7. Mohrenweiser H.W., Jones I.M. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat. Res. 400:1998;15-24.
8. Parshad R., Price F.M., Bohr V.A., Cowans K.H., Zujewski J.A., Sanford K.K. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer. 74:1996;1-5.
9. J. Cole, T.R. Skopek, International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper No. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo, Mutat. Res., 304 (1994) 33-105.
10. Hirota H., Kubota M., Adachi S., Okuda A., Lin Y.W., Bessho R., Wakazono Y., Matsubara K., Kuwakado K., Akiyama Y.et al. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation. Mutat. Res. 315:1994;95-103.
11. Albertini R.J., Nicklas J.A., Fuscoe J.C., Skopek T.R., Branda R.F., O'Neill J.P. In vivo mutations in human blood cells: biomarkers for molecular epidemiology. Environ. Health Perspect. 99:1993;135-141.
12. Albertini R.J., Nicklas J.A., O'Neill J.P., Robison S.H. In vivo somatic mutations in humans: measurement and analysis. Annu. Rev. Genet. 24:1990;305-326.
13. Langlois R.G., Bigbee W.L., Kyoizumi S., Nakamura N., Bean M.A., Akiyama M., Jensen R.H. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science. 236:1987;445-448.
14. Kyoizumi S., Nakamura N., Hakoda M., Awa A.A., Bean M.A., Jensen R.H., Akiyama M. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res. 49:1989;581-588.
15. Hirai Y., Kusunoki Y., Kyoizumi S., Awa A.A., Pawel D.J., Nakamura N., Akiyama M. Mutant frequency at the HPRT locus in peripheral blood T-lymphocytes of atomic bomb survivors. Mutat. Res. 329:1995;183-196.
16. Awa A.A., Nakano M., Ohtaki K., Kodama Y., Lucas J., Gray J. Factors that determine the in vivo dose-response relationship for stable chromosome aberrations in A-bomb survivors. J. Rad. Res. 33:1992;206-214.
17. Hakoda M., Akiyama M., Kyoizumi S., Awa A.A., Yamakido M., Otake M. Increased somatic cell mutant frequency in atomic bomb survivors. Mutat. Res. 201:1988;39-48.
18. Nicklas J.A., O'Neill J.P., Hunter T.C., Falta M.T., Lippert M.J., Jacobson-Kram D., Williams J.R., Albertini R.J. In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes. Mutat. Res. 250:1991;383-396.
19. Nicklas J.A., Falta M.T., Hunter T.C., O'Neill J.P., Jacobson-Kram D., Williams J.R., Albertini R.J. Molecular analysis of in vivo hprt mutations in human T lymphocytes: V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT). Mutagenesis. 5:1990;461-468.
20. Messing K., Bradley W.E.C. In vivo mutant frequency rises among breast cancer patients after exposure to high doses of γ radiation. Mutat. Res. 152:1985;107-112.
21. Sala-Trepat M., Cole J., Green M.H., Rigaud O., Vilcoq J.R., Moustacchi E. Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients: III. Measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis. 5:1990;593-598.
22. Dempsey J.L., Seshadri R.S., Morley A.A. Increased mutant frequency following treatment with cancer chemotherapy. Cancer Res. 45:1985;2873-2877.
23. Seifert A.M., Bradley W.E.C., Messing K. Exposure of nuclear medicine patients to ionizing radiation is associated with rises in HPRT-mutant frequency in peripheral T-lymphocytes. Mutat. Res. 191:1987;57-63.
24. m in nuclear medicine patients does not induce detectable genetic effects. Mutat. Res. 264:1991;213-218.
25. m in vivo labelled erythrocytes does not lead to induction of mutations in the HPRT gene of human T-lymphocytes. J. Nucl. Med. 32:1991;814-819.
26. Messing K., Seifert A.M., Bradley W.E. In vivo mutant frequency of technicians professionally exposed to ionizing radiation. Prog. Clin. Biol. Res. 207:1986;87-97.
27. Seifert A.M., Demers C., Dubeau H., Messing K. HPRT-mutant frequency and lymphocyte characteristics of workers exposed to ionizing radiation on a sporadic basis: a comparison of two exposure indicators, job title and dose. Mutat. Res. 319:1993;61-70.
28. Cole J., Arlett C.F., Green M.H., Holdsworth D., Tawn E.J., Bridges B.A. Mutant frequencies in workers at the Sellafield installation. Health Physics. 68:1995;388-393.
29. Bridges B.A., Cole J., Arlett C.F., Green M.H., Waugh A.P., Beare D., Henshaw D.L., Last R.D. Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet. 337:1991;1187-1189.
30. Cole J., Green M.H., Bridges B.A., Waugh A.P., Beare D.M., Henshaw D., Last R., Liu Y., Cortopassi G. Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home. Rad. Res. 145:1996;61-69.
31. Ostrosky-Wegman P., Montero R., Palao A., Cortinas de Nava C., Hurtado F., Albertini R.J. 6-Thioguanine-resistant T-lymphocyte autoradiographic assay. Determination of variation frequencies in individuals suspected of radiation exposure. Mutat. Res. 232:1990;49-56.
32. Saddi V., Curry J., Nohturfft A., Kusser W., Glickman B.W. Increased hprt mutant frequencies in Brazilian children accidentally exposed to ionizing radiation. Environ. Mol. Mutagen. 28:1996;267-275.
33. da Cruz A.D., Curry J., Curado M.P., Glickman B.W. Monitoring hprt mutant frequency over time in T-lymphocytes of people accidentally exposed to high doses of ionizing radiation. Environ. Mol. Mutagen. 27:1996;165-175.
34. Skandalis A., da Cruz A.D., Curry J., Nohturfft A., Curado M.P., Glickman B.W. Molecular analysis of T-lymphocyte HPRT-mutations in individuals exposed to ionizing radiation in Goiania, Brazil. Environ. Mol. Mutagen. 29:1997;107-116.
35. Vrieling H., Thijssen J.C.P., Rossi A.M., Van Dam F.J., Natarajan A.T., Tates A.D., van Zeeland A.A. Enhanced hprt mutant frequency but no significant difference in mutation spectrum between a smoking and a non-smoking human population. Carcinogenesis. 12:1992;1625-1631.
36. Wones R., Radack K., Martin V., Mandell K., Pinney S., Buncher R. Do persons living near a uranium processing site have evidence of increased somatic cell gene mutations? A first study. Mutat. Res. 335:1995;171-184.
37. Moore D.H. II, Tucker J.D., Jones I.M., Langlois R.G., Pleshanov P., Vorobtsova I., Jensen R. A study of the effects of exposure on cleanup workers at the Chernobyl nuclear reactor accident using multiple end points. Rad. Res. 148:1997;463-475.
38. Jones I.M., Moore D.H., Thomas C.B., Thompson C.L., Strout C.L., Burkhart-Schultz K. Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 2:1993;249-260.
39. Duthie S.J., Ross M., Collins A.R. The influence of smoking and diet on the hypoxanthine phosphoribosyltransferase (hprt) mutant frequency in circulating T lymphocytes from a normal human population. Mutat. Res. 331:1995;55-64.
40. Jones I.M., Thomas C.B., Tucker B., Thompson C.L., Pleshanov P., Vorobtsova I., Moore D.H. Impact of age and environment on somatic mutation at the hprt gene of T lymphocytes in humans. Mutat. Res. 338:1995;129-139.
41. O'Neill J.P., McGinniss M.J., Berman J.K., Sullivan L.M., Nicklas J.A., Albertini R.J. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis. 2:1987;87-94.
42. O'Neill J.P., Sullivan L.M., Booker J.K., Pornelos B.S., Falta M.T., Greene C.J., Albertini R.J. Longitudinal study of the in vivo hprt mutant frequency in human T-lymphocytes as determined by a cell cloning assay. Environ. Mol. Mutagen. 13:1989;289-293.
43. Furth E.E., Thilly W.G., Penman B.W., Liber H.L., Rand W.M. Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal. Biochem. 110:1981;1-8.
44. Henderson L., Cole H., Cole J., James S.E., Green M. Detection of somatic mutations in man: evaluation of the microtitre cloning assay for T-lymphocytes. Mutagenesis. 1:1986;195-200.
45. P. McCullagh, J.A. Nelder, Generalized Linear Models, Chapman & Hall, London, 1989.
46. SAS Institute, SAS/STAT User's Guide®, Version 6, SAS Institute, Cary, NC, 1989.
47. B. Francis, M. Green, C. Payne, The GLIM System - Release 4 - Manual, Numerical Algorithms Group, Oxford, England, 1993.
48. W.N. Venables, B.D. Ripley, Modern Applied Statistics with S-PLUS, Springer, New York, 1997.
49. R.H. Myers, Classical and Modern Regression with Applications, PWS-Kent, Boston, 1990.
50. J.M. Chambers, T.J. Hastie, Statistical Models, S. Wadsworth and Brooks, Pacific Grove, CA, 1992.
51. Hadi A.S., Simonoff J.S. Procedures for the identification of multiple outliers in linear models. J. Am. Stat. Assoc. 88:1993;1264-1272.
52. Zellner A. An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. J. Am. Stat. Assoc. 57:1962;348-368.
53. V.K. Srivastara, D.E.A. Giles, Seemingly Unrelated Regression Equations Models. Estimation and Inference, Dekker, New York, 1987.
54. Lin C.T. The efficiency of least-squares estimators of a seemingly unrelated regression model. Communication in Statistics Simulation and Computation. 20:1991;919-925.
55. Robinson D.R., Goodall K., Albertini R.J., O'Neill J.P., Finete B., Sala-Trepat M., Moustacchi E., Tates A.D., Beare D.M., Green M.H.L., Cole J. An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. Mutat. Res. 313:1994;227-247.
56. Morley A.A. The estimation of in vivo mutation rate and frequency from samples of human lymphocytes. Mutat. Res. 357:1996;167-176.
57. W.A. Fuller, Measurement Error Models, Wiley, New York, 1987.
58. R.J. Carroll, D. Ruppert, L.A. Stefanski, Measurement Error in Nonlinear Models, Chapman & Hall, London, 1995.
59. S. Umeki, S. Kyoizumi, Y. Kusunoki, N. Nakamura, S.M. Sasaki, T. Mori, Y. Ishikawa, J.B. Cologne, M. Akiyama, Somatic mutation at the TCR loci as a biological dosimeter of radiation-exposed people, in: International Conference on Radiation Effects and Protection, Japan Atomic Energy Research Institute, Tokyo, 1993, pp. 151-154.
60. McGinniss M.J., Nicklas J.A., Albertini R.J. Molecular analyses of in vivo hprt mutations in human T-lymphocytes: IV. Studies in newborns. Environ. Mol. Mutagen. 14:1989;229-237.
61. Finette B.A., Sullivan L.M., O'Neill J.P., Nicklas J.A., Vacek P.M., Albertini R.J. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat. Res. 308:1994;223-231.
62. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Burnette L., Moore M.M., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutat. Res. 283:1992;13-20.
63. Fuscoe J.C., Zimmerman L.J., Lippert M.J., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res. 51:1991;6001-6005.
64. Deubel W., Bassukas I.D., Schlereth W., Lorenz R., Hempel K. Age dependent selection against HPRT deficient T lymphocytes in the HPRT+/- heterozygous mouse. Mutat. Res. 351:1996;67-77.
65. Gaziev A.I., Podlutsky A., Panfilov B.M., Bradbury R. Dietary supplements of antioxidants reduce hprt mutant frequency in splenocytes of aging mice. Mutat. Res. 338:1995;77-86.
66. Lorenz R., Leuner K., Deubel W., Gollner T., Hempel K. Normal and reverse dose-rate effect for the induction of mutants in somatic cells by ionizing radiation. Toxicol. Lett. 67:1993;353-363.
67. Bigbee W.L., Jensen R.H., Veidebaum T., Tekkel M., Rahu M., Stengrevics A., Auvinen A., Hakulinen T., Servomaa K., Rytömaa T., Obrams G.I., Boice J.D. Jr. Biodosimetry of Chernobyl cleanup workers from Estonia and Latvia using the glycophorin A in vivo somatic cell mutation assay. Rad. Res. 147:1997;215-224.
68. Tucker J.D., Tawn E.J., Holdsworth D., Morris S., Langlois R., Ramsey M.J., Kato P., Boice J.D. Jr., Tarone R.E., Jensen R.H. Biological dosimetry of radiation workers at the Sellafield Nuclear Facility. Rad. Res. 148:1997;216-226.
69. Spruill M.D., Ramsey M.J., Swiger R.R., Nath J., Tucker J.D. The persistence of aberrations in mice induced by gamma radiation as measured by chromosome painting. Mutat. Res. 356:1996;135-145.
70. Tucker J.D., Breneman J.W., Briner J.F., Eveleth G.G., Langlois R.G., Moore D.H. II The persistence of radiation-induced translocations in rat peripheral blood determined by chromosome painting. Environ. Mol. Mutagen. 30:1997;264-272.
71. Matsumoto K., Ramsey M.J., Nelson D.O., Tucker J.D. Persistence of radiation-induced translocations in human peripheral blood determined by chromosome painting. Rad. Res. 149:1998;602-613.
72. Furuno-Fukushi I., Tatsumi K., Takahagi M., Tachibana A. Quantitative and qualitative effect of γ-ray dose rate on mutagenesis in human lymphoblastoid cells. Int. J. Rad. Biol. 70:1996;209-217.
73. Grosovsky A.J., Little J.B. Evidence for linear response for the induction of mutations in human cells by X-ray exposures below 10 rads. Proc. Natl. Acad. Sci. USA. 82:1985;2092-2095.
74. Nelson S.L., Parks K.K., Grosovsky A.J. Ionizing radiation signature mutations in human cell mutants induced by low-dose exposures. Mutagenesis. 11:1996;275-279.
75. Mei N., Kunugita N., Nomoto S., Norimura T. Comparison of the frequency of T-cell receptor mutants and thioguanine resistance induced by X-rays and ethylnitrosourea in cultured human blood T-lymphocytes. Mutat. Res. 357:1996;191-197.
76. Vijayalaxmi, Evans H.J. Measurement of spontaneous and X-irradiation-induced 6-thioguanine-resistant human blood lymphocytes using a T-cell cloning technique. Mutat. Res. 125:1984;87-94.
77. Burkhart-Schultz K.J., Jones I.M. Deletion and insertion in vivo somatic mutations in hypoxanthine phosphoribosyltransferase (hprt) gene of human T-lymphocytes. Environ. Mol. Mutagen. 30:1997;371-384.
78. Nelson S.L., Jones I.M., Fuscoe J.C., Burkhart-Schultz K., Grosovsky A.J. Mapping the end points of large deletions affecting the hprt locus in human peripheral blood cells and cell lines. Rad. Res. 141:1995;2-10.